Scarica l'app Stockscreener
11.44
0.79%
0.09
Dopo l'orario di chiusura:
11.44
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVTR Giù?
Forum
Previsione
Precedente Chiudi:
$11.35
Aprire:
$11.39
Volume 24 ore:
12.28M
Relative Volume:
1.26
Capitalizzazione di mercato:
$7.81B
Reddito:
$6.55B
Utile/perdita netta:
$-551.40M
Rapporto P/E:
-14.15
EPS:
-0.8082
Flusso di cassa netto:
$438.90M
1 W Prestazione:
+3.34%
1M Prestazione:
+18.06%
6M Prestazione:
-3.05%
1 anno Prestazione:
-18.34%
Intervallo 1D:
$11.32
$11.61
Intervallo di 1 settimana:
$10.19
$11.75
Portata 52W:
$7.265
$15.93
Avantor Inc Stock (AVTR) Company Profile
Nome
Avantor Inc
Settore
Industria
Telefono
(610) 386-1700
Indirizzo
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVTR
Avantor Inc
|
11.44 | 7.81B | 6.55B | -551.40M | 438.90M | -0.8082 |
ISRG
Intuitive Surgical Inc
|
337.50 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
156.36 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.91 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
38.75 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
195.27 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-06 | Downgrade | Barclays | Equal Weight → Underweight |
| 2026-01-05 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-12-17 | Downgrade | Jefferies | Hold → Underperform |
| 2025-12-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-11-04 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2025-10-30 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-10-30 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-08-01 | Downgrade | Jefferies | Buy → Hold |
| 2025-04-29 | Downgrade | Goldman | Buy → Neutral |
| 2025-04-28 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-04-28 | Downgrade | Stifel | Buy → Hold |
| 2025-04-28 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-17 | Downgrade | UBS | Buy → Neutral |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-07-10 | Downgrade | Citigroup | Buy → Neutral |
| 2024-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-12-11 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-07-31 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-06-21 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-10-05 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-09-14 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-09-09 | Downgrade | Cleveland Research | Buy → Neutral |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-04 | Downgrade | Citigroup | Buy → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-30 | Ripresa | Raymond James | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-08-02 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-06-04 | Iniziato | Goldman | Buy |
| 2021-04-29 | Aggiornamento | Stifel | Hold → Buy |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-08-02 | Iniziato | Cleveland Research | Neutral |
| 2019-06-14 | Iniziato | Janney | Buy |
| 2019-06-12 | Iniziato | Raymond James | Outperform |
| 2019-06-11 | Iniziato | Goldman | Buy |
| 2019-06-11 | Iniziato | Guggenheim | Buy |
| 2019-06-11 | Iniziato | JP Morgan | Overweight |
| 2019-06-11 | Iniziato | Jefferies | Buy |
| 2019-06-11 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-06-11 | Iniziato | Piper Jaffray | Neutral |
| 2019-06-11 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-06-11 | Iniziato | Robert W. Baird | Outperform |
| 2019-06-11 | Iniziato | SunTrust | Buy |
| 2019-06-11 | Iniziato | UBS | Buy |
| 2019-06-11 | Iniziato | William Blair | Outperform |
Mostra tutto
Avantor Inc Borsa (AVTR) Ultime notizie
Avantor, Inc. Revenue Breakdown – BMV:AVTR - TradingView
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Avantor, Inc. (AVTR) Stock forecasts - Yahoo Finance Singapore
Avantor, Inc. (AVTR) Stock Forecasts - Yahoo Finance
Avantor Inc (AVTR) Stock Up 3.6% and Still Undervalued -- GF Sco - GuruFocus
Avantor stock holds steady as investors weigh recent earnings and life sciences demand - AD HOC NEWS
AVTR: Avantor Inc. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Shareholders to Reach Out - ACCESS Newswire
Avantor, Inc. (AVTR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
Avantor stock trades steady as investors weigh recent earnings and life sciences demand - AD HOC NEWS
Avantor Inc (AVTR) Shares Fall 3.7% -- What GF Score of 61 Tells Investors - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
2026-07-19 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Shareholders to Learn More About the Investigation | NYSE:AVTR | Press Release - Stockhouse
Avantor, Inc. Announces Amendment No. 15 to Credit Agreement, Extending Euro Term Loan Maturity to 2032 - Minichart
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Avantor Lowers Borrowing Costs by Refinancing €374.2 Million Euro-Denominated Term Loans with Credit Agreement Amendment - Kalkine Media
Avantor Unit Enters Amendment No. 15 To Credit Agreement On July 14, 2026SEC Filing - TradingView
Avantor Refinances €374.2 Million Euro Term Loans at EURIBO + 2.00% Under Credit Amendment - TradingView
Avantor (NYSE: AVTR) refinances €374,208,296.62 in Euro term loans - Stock Titan
Trading Systems Reacting to (AVTR) Volatility - Stock Traders Daily
Will Avantor (AVTR) beat estimates again in its next earnings report? - MSN
Is Avantor (AVTR) Quietly Redefining Its Healthcare Role With NuSil’s HIV-Prevention Partnership? - simplywall.st
Will Avantor (AVTR) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Avantor Stock Up on NuSil's Expanded HIV Prevention Partnership - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Avantor Jumps 6.2% Amid Sector-Wide Rally - AlphaStreet
Avantor Inc (AVTR) Stock Up 6.9% and Still Undervalued -- GF Sco - GuruFocus
Avantor expands partnership for HIV prevention ring development By Investing.com - Investing.com Nigeria
Avantor expands partnership for HIV prevention ring development - Investing.com
Avantor expands collaboration to develop a thre... - Pluang
New HIV prevention ring could cut use from 12 rings to four - Stock Titan
Price to earnings forward of Avantor, Inc. – LSX:A2PJN6 - TradingView
Avantor, Inc. Stock 12‑Month Price Target Raised to $10.31, Implies 1% Downside - TradingView
BofA Securities Adjusts Avantor Price Target to $12 From $10 - Moomoo
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Avantor (AVTR) Gains Traction Under New Management - Yahoo Finance
Avantor, Inc. Stock 12‑Month Price Target Raised to $10.19, Implies 2% Downside - TradingView
Enterprise value to EBITDA forward of Avantor, Inc. – LSX:A2PJN6 - TradingView
Investors in Avantor, Inc. (AVTR): Protect Your Rights – Contact Levi & Korsinsky Before December 29, 2025 - The National Law Review
Avantor stock reflects steady life sciences demand amid global biosciences expansion - ad-hoc-news.de
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avantor, Inc. (AVTR) And Encourages Investors to Connect - ACCESS Newswire
Here's why you should hold Avantor stock in your portfolio for now - MSN
Avantor Inc (AVTR) Stock Up 7.7% and Still Undervalued -- GF Sco - GuruFocus
Avantor stock reflects life science demand amid diversified growth - ad-hoc-news.de
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now - TradingView
Avantor Price Target Raised to $11.00/Share From $9.00 by Citigroup - Moomoo
Avantor Is Maintained at Neutral by Citigroup - Moomoo
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Avantor Inc focuses on life sciences growth while investors monitor its Nasdaq listing - ad-hoc-news.de
Evercore Maintains Avantor(AVTR.US) With Hold Rating, Raises Target Price to $10.5 - Moomoo
Avantor Is Maintained at In-Line by Evercore ISI Group - Moomoo
Avantor Inc Azioni (AVTR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.37%
0.73%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):